Handelsbanken Fonder’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.86M | Sell |
25,281
-2,700
| -10% | -$198K | 0.01% | 688 |
|
2025
Q1 | $3.2M | Hold |
27,981
| – | – | 0.01% | 516 |
|
2024
Q4 | $1.41M | Sell |
27,981
-3,000
| -10% | -$151K | 0.01% | 813 |
|
2024
Q3 | $1.43M | Buy |
30,981
+11,700
| +61% | +$542K | 0.01% | 789 |
|
2024
Q2 | $626K | Sell |
19,281
-600
| -3% | -$19.5K | ﹤0.01% | 1059 |
|
2024
Q1 | $501K | Hold |
19,881
| – | – | ﹤0.01% | 1159 |
|
2023
Q4 | $646K | Hold |
19,881
| – | – | ﹤0.01% | 1005 |
|
2023
Q3 | $542K | Buy |
19,881
+2,000
| +11% | +$54.5K | ﹤0.01% | 1016 |
|
2023
Q2 | $398K | Hold |
17,881
| – | – | ﹤0.01% | 1186 |
|
2023
Q1 | $387K | Hold |
17,881
| – | – | ﹤0.01% | 1136 |
|
2022
Q4 | $363K | Sell |
17,881
-5,079
| -22% | -$103K | ﹤0.01% | 1142 |
|
2022
Q3 | $589K | Hold |
22,960
| – | – | ﹤0.01% | 873 |
|
2022
Q2 | $546K | Sell |
22,960
-400
| -2% | -$9.51K | ﹤0.01% | 969 |
|
2022
Q1 | $526K | Sell |
23,360
-4,400
| -16% | -$99.1K | ﹤0.01% | 1168 |
|
2021
Q4 | $550K | Hold |
27,760
| – | – | ﹤0.01% | 1279 |
|
2021
Q3 | $546K | Hold |
27,760
| – | – | ﹤0.01% | 1299 |
|
2021
Q2 | $611K | Buy |
27,760
+10,400
| +60% | +$229K | ﹤0.01% | 1232 |
|
2021
Q1 | $413K | Hold |
17,360
| – | – | ﹤0.01% | 1296 |
|
2020
Q4 | $454K | Hold |
17,360
| – | – | ﹤0.01% | 1209 |
|
2020
Q3 | $302K | Hold |
17,360
| – | – | ﹤0.01% | 1234 |
|
2020
Q2 | $292K | Buy |
+17,360
| New | +$292K | ﹤0.01% | 1230 |
|